Published on
June 24, 2026
- 15:04 GMT
HistoSpring Announces Issuance of U.S. Patent for Methods Predicting ER-Mediated DNA Damage
Novel technology provides a new approach for identifying estrogenic compounds associated with genomic instability and breast cancer risk SPRINGFIELD, MA, UNITED STATES, June 24, 2026 /EINPresswire.com/ -- HistoSpring, a leading provider of …
Distribution channels:
Companies, Environment
...
